Article
Effects of APOE ε4 and amyloid pathology on longitudinal tau biomarkers, neurodegeneration, and cognitive decline in mild cognitive impairment.
Journal of Alzheimer's disease : JAD - 1 May 2026
Wang Xitian, Zhang Chunhua, Liu Xiaocong, Tai Yaojun, Ma Guozhao, Kong Min, Ba Maowen
Abstract excerpt
BackgroundMild cognitive impairment (MCI) confers an increased risk of Alzheimer's disease (AD). The apolipoprotein E (APOE) ε4 allele is a major genetic risk factor for late-onset AD and is strongly associated with amyloid-β (Aβ) pathology. However, whether Aβ burden is associated with APOE ε4-related longitudinal changes in tau pathology, neurodegeneration, and cognitive decline in MCI remains incompletely...
Topics
- Humans
- Cognitive Dysfunction
- tau Proteins
- Male
- Apolipoprotein E4
- Female
- Aged
- Longitudinal Studies
- Biomarkers
- Amyloid beta-Peptides
- Aged, 80 and over
